These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8588133)

  • 21. HCV viral load in anti-HCV-reactive donors and infectivity for their recipients.
    Operskalski EA; Mosley JW; Tobler LH; Fiebig EW; Nowicki MJ; Mimms LT; Gallarda J; Phelps BH; Busch MP; ;
    Transfusion; 2003 Oct; 43(10):1433-41. PubMed ID: 14507276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].
    Durand F; Danic B; Tardivel R; Semana G; Gouezec H; Martinot M; Marcellin P; Beauplet A
    Transfus Clin Biol; 2000 Jun; 7(3):242-50. PubMed ID: 10919211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation.
    Candinas D; Joller-Jemelka HI; Schlumpf R; Wicki A; Mutimer DJ; Keusch G; Largiadèr F
    J Med Microbiol; 1994 Oct; 41(4):220-3. PubMed ID: 7523676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C lookback programme: a single hospital experience.
    Pawson R; Rajan S; Hazlehurst G; Dusheiko G; Miller R; Hewitt P; Mehta A
    Transfus Med; 1999 Sep; 9(3):189-93. PubMed ID: 10555811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis C infection and its associated factors in healthy adults without identifiable route of transmission.
    Wong NS; Lee CK; Ng SC; Wong HK; Chan DPC; Lee SS
    J Viral Hepat; 2018 Feb; 25(2):161-170. PubMed ID: 29032634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCR testing for HCV in anti-HCV negative blood donors involved in the so called HCV +ve post-transfusion hepatitis.
    Ruzzenenti MR; De Luigi MC; Bruni R; Giannini G; Bo A; Valbonesi M; Barresi R; Torretta F; Gianotti P; Bruzzone B
    Transfus Sci; 2000 Jun; 22(3):161-4. PubMed ID: 10831918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors.
    Moore SB; Kruger JR; Rakela J; Vamvakas EC; Schimek C; Germer JJ; Persing DH
    Transfusion; 1995 Apr; 35(4):308-12. PubMed ID: 7701548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Follow-up of blood donors with positive serology for hepatitis C virus and their recipients is insufficient].
    Bonaguidi-Magniaux M; Pilette C; Oberti F; Bidet ML; Calès P
    Gastroenterol Clin Biol; 1996; 20(8-9):663-8. PubMed ID: 8977814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus RNA (HCV-RNA) in blood donors and family members seropositive for anti-HCV antibodies.
    Alvarez-Muñoz MT; Vences-Aviles MA; Damacio L; Vázquez-Rosales G; Torres J; González-Bravo F; Muñoz O
    Arch Med Res; 2001; 32(5):442-5. PubMed ID: 11578761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Natural clearance of hepatitis C virus in 96 patients with infection acquired by blood transfusion from a single donor in Guizhou].
    Liu S; Cheng M; Mu M; Yang Q
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):251-4. PubMed ID: 25173221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should hepatitits-C virus antibody-positive donors be excluded from kidney donation?
    Pouteil-Noble C; Tardy JC; Chossegros P; Trepo C; Aymard M; Touraine JL
    Transpl Int; 1992; 5 Suppl 1():S44-6. PubMed ID: 14621728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
    Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
    Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors.
    Shev S; Foberg U; Fryden A; Hermodsson S; Lindh G; Lindholm A; Månsson AS; von Sydow M; Weiland O; Widell A
    Vox Sang; 1993; 65(1):32-7. PubMed ID: 7689776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
    Kiely P; Kay D; Parker S; Piscitelli L
    Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.